Eurofins Reinforces Its Leadership in the Benelux Food and Feed Testing Market with the Acquisition of KBBL
February 28 2014 - 2:00AM
Business Wire
Regulatory News :
Eurofins Scientific (Paris:ERF) (EUFI.PA), the global leader in
food and feed testing, announces the acquisition of KBBL, one of
the leading food and water testing service providers in The
Netherlands, from Gezondheidsdienst voor Dieren (GD), a leading
company in animal health management.
KBBL generates revenues in excess of EUR 7m, and has established
a strong reputation in the domestic food and water testing market
since its foundation in 1990. It is also a reference laboratory for
meat testing. KBBL offers the full spectrum of analytical testing
for the food industry and enjoys long-standing relationship with
food producers, consultancy firms and other laboratories in the
domestic market. As part of the transaction, Eurofins will continue
a strategic cooperation with GD providing it with analytical
services geared for the food sector.
KBBL is a strategic fit for Eurofins both in operational
competence, and geographic location. The acquisition provides
Eurofins access to the complex but attractive domestic meat testing
market, and allows KBBL to further develop this competence, whilst
Eurofins can provide a more optimal platform for other laboratory
activities that they currently perform at low volumes. In addition,
KBBL’s competence in drinking water testing reinforces Eurofins’
leadership in this market. Furthermore, KBBL’s laboratory is
ideally located in Wijhe, between Eurofins’ food testing hubs in
Heerenveen and Barendrecht, and is in close proximity to the
Group’s water testing activities in Deventer, for easy access to
the various competencies and logistical network of the Group.
For more information, please visit
www.eurofins.com
Notes for the editor:
Eurofins – a global leader in bio-analysisEurofins
Scientific is the world leader in food and pharmaceutical products
testing. It is also number one in the world in the field of
environmental laboratory services and one of the global market
leaders in agroscience, genomics, discovery pharmacology and
central laboratory services.
With about 15,000 staff in more than 190 laboratories across 36
countries, Eurofins offers a portfolio of over 100,000 reliable
analytical methods for evaluating the safety, identity,
composition, authenticity, origin and purity of biological
substances and products. The Group provides its customers with
high-quality services, accurate results in time and expert advice
by its highly qualified staff.
Eurofins is committed to pursuing its dynamic growth strategy by
expanding both its technology portfolio and its geographic reach.
Through R&D and acquisitions, the Group draws on the latest
developments in the field of biotechnology and analytical chemistry
to offer its clients unique analytical solutions and the most
comprehensive range of testing methods.
As one of the most innovative and quality oriented international
players in its industry, Eurofins is ideally positioned to support
its clients’ increasingly stringent quality and safety standards
and the expanding demands of regulatory authorities around the
world.
The shares of Eurofins Scientific are listed on the NYSE
Euronext Paris Stock Exchange (ISIN FR0000038259, Reuters EUFI.PA,
Bloomberg ERF FP).
Important disclaimer:
This press release contains forward-looking statements and
estimates that involve risks and uncertainties. The forward-looking
statements and estimates contained herein represent the judgement
of Eurofins Scientific’ management as of the date of this release.
These forward-looking statements are not guarantees for future
performance, and the forward-looking events discussed in this
release may not occur. Eurofins Scientific disclaims any intent or
obligation to update any of these forward-looking statements and
estimates. All statements and estimates are made based on the
information available to the Company’s management as of the date of
publication, but no guarantee can be made as to their validity.
EurofinsInvestor RelationsPhone: +32-2-766 1620E-mail:
ir@eurofins.com
Enerplus (NYSE:ERF)
Historical Stock Chart
From Jun 2024 to Jul 2024
Enerplus (NYSE:ERF)
Historical Stock Chart
From Jul 2023 to Jul 2024